Mustang Bio (NASDAQ:MBIO – Get Rating) and Aridis Pharmaceuticals (NASDAQ:ARDS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Risk and Volatility Mustang Bio has a beta of […]